• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/10 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 207/10

Total number of patents in this class: 172

10-year publication summary

12
25
12
9
12
9
9
5
10
6
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
3m Innovative Properties Company
17455
10
Bodor Laboratories, Inc.
59
10
F. Hoffmann-La Roche AG
7798
9
Corteva Agriscience LLC
2649
9
Hoffmann-La Roche Inc.
3841
8
Tetraphase Pharmaceuticals, Inc.
52
6
VALO Health, Inc.
195
5
Daiichi Sankyo Company, Limited
1890
4
Novartis AG
10169
3
Bayer Pharma AG
1005
3
California Institute of Technology
4038
3
KYORIN Pharmaceutical Co., Ltd.
154
3
Taisho Pharmaceutical Co., Ltd.
846
3
Toyama Chemical Co., Ltd.
88
3
Rappta Therapeutics Oy
10
3
Bristol-myers Squibb Company
4757
2
AstraZeneca AB
2823
2
Board of Regents, The University of Texas System
6172
2
The Regents of the University of Michigan
5038
2
The Cleveland Clinic Foundation
1583
2
Other owners 80